Washington, D.C.—September 14, 2018—Today a lawsuit was filed in U.S. District Court to stop the implementation of a rule governing short-term limited duration insurance plans (STLD).
Congress is poised to pass a funding bill that includes a $2 billion increase for medical research at the National Institutes of Health (NIH) later this month as part of a combined Defense and Labor, Health and Human Services (LHHS) bill introduced today.
Statement of the American Academy of Pediatrics, Massachusetts Chapter of the American Academy of Pediatrics, American Cancer Society, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids and Truth Initiative
Legislation before Congress aims to protect patients should the plaintiffs win their court challenge. The bill would prohibit health plans from charging people more or denying them coverage due to their health status or pre-existing conditions. However, it would allow plans to exclude or restrict coverage for those pre-existing conditions
Senator Tammy Baldwin (D-Wis.) has introduced a resolution under the Congressional Review Act that would prevent the extension and expansion of short-term limited duration health insurance plans (STLD) as allowed under a new rule from the Departments of Health and Human Services (HHS) and Treasury.
Twenty-two public health and patient advocacy groups submitted a letter to the United States Preventive Services Task Force (USPSTF) today requesting it reconsider its 2016 colorectal cancer screening recommendation before its currently scheduled review in 2021.
The U.S. Senate approved an FY 2019 spending bill today that includes a $2 billion funding increase for the National Institutes of Health (NIH) and a $190 million funding boost for the National Cancer Institute (NCI).
The Center for Medicare and Medicaid Services (CMS) issued guidance last night giving Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs, effective January 1, 2019.
The Department of Health and Human Services (HHS), Department of Labor and Department of Treasury issued a final rule governing the extension of short-term limited-duration plans. Under the rule, insurers can issue new short-term plans that can be extended for up to 36 months.
Today the American Cancer Society Cancer Action Network submitted comments to the Department of Health and Human Services (HHS) regarding proposals to reduce prescription drug costs outlined in the administration’s Request for Information (RFI) regarding its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (blueprint).